Search alternatives:
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 mg » 5 mm (Expand Search)
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 mg » 5 mm (Expand Search)
-
40041
Study protocol.
Published 2024“…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
-
40042
S1 Data -
Published 2024“…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
-
40043
-
40044
Repair of subtotal tympanic membrane perforations: A temporal bone study of several tympanoplasty materials
Published 2019“…Five different graft materials (1) perichondrium (2) silastic (3) thin cartilage (4) thick cartilage (5) Lotriderm<sup>®</sup> cream were used to reconstruct each perforation condition. …”
-
40045
-
40046
datasheet1_Unraveling the Contribution of Fluid Therapy to the Development of Augmented Renal Clearance in a Piglet Model.pdf
Published 2021“…In addition, the hydrophilic antibiotic amikacin (7.5 mg/kg BW) was administered. Following this baseline measurement, the treatment group received fluid therapy as a constant rate infusion of 0.9% saline at 6 mL/kg/h over 36 h. …”
-
40047
Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation
Published 2006“…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”
-
40048
Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation
Published 2006“…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”
-
40049
Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation
Published 2006“…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”
-
40050
Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation
Published 2006“…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”
-
40051
Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation
Published 2006“…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”
-
40052
Image2_A Role of Caveolae in Trabecular Meshwork Mechanosensing and Contractile Tone.JPEG
Published 2022“…Treatment with the Cav1 scaffolding domain mimetic, cavtratin (1 μM) caused a reduction in pMLC (70 ± 5% n = 7, p = 0.001), as did treatment with the scaffolding domain mutant cavnoxin (1 μM) (82 ± 7% n = 7, p = 0.04). …”
-
40053
Genetic Ancestry-Smoking Interactions and Lung Function in African Americans: A Cohort Study
Published 2012“…African Americans with a high proportion of African ancestry had lower baseline forced expiratory volume in one second (FEV<sub>1</sub>) per pack-year of smoking (−5.7 ml FEV<sub>1</sub>/ smoking pack-year) compared with smokers with lower African ancestry (−4.6 ml in FEV<sub>1</sub>/ smoking pack-year) (interaction <em>P</em> value = 0.17). …”
-
40054
Image4_A Role of Caveolae in Trabecular Meshwork Mechanosensing and Contractile Tone.JPEG
Published 2022“…Treatment with the Cav1 scaffolding domain mimetic, cavtratin (1 μM) caused a reduction in pMLC (70 ± 5% n = 7, p = 0.001), as did treatment with the scaffolding domain mutant cavnoxin (1 μM) (82 ± 7% n = 7, p = 0.04). …”
-
40055
DataSheet1_Examining the paradoxical effects of kratom: a narrative inquiry.PDF
Published 2023“…Five of the 10 participants met DSM-5-based criteria for kratom-use disorder (3 mild, 1 moderate, 1 severe, by symptoms counts). …”
-
40056
Relationship between Circulating and Tissue microRNAs in a Murine Model of Breast Cancer
Published 2012“…Athymic nude mice (n = 20) received either a mammary fat pad (n = 8, MFP), or subcutaneous (n = 7, SC) injection of MDA-MB-231 cells. …”
-
40057
The prostate after castration and hormone replacement in a rat model: structural and ultrastructural analysis
Published 2017“…The androgen deprivation promoted several alterations in the prostate: the acinar epithelium height diminished from 16.58±0.47 to 11.48±0.29μm; the number of mast cells per field presented increased from 0.45±0.07 to 2.83±0.25; collagen fibers density increased from 5.83±0.92 to 24.70±1.56%; and acinar lumen density decreased from 36.78±2.14 to 16.47±1.31%. …”
-
40058
Table 1_A retrospective analysis of 38,652 amniotic fluid karyotype.xlsx
Published 2025“…Chromosome breakage was most common in chromosomes Y and 1, whereas deletions were most frequently detected in chromosomes X and 5. Isochromosomes mainly appeared in a mosaic form in chromosome X. …”
-
40059
Image3_A Role of Caveolae in Trabecular Meshwork Mechanosensing and Contractile Tone.JPEG
Published 2022“…Treatment with the Cav1 scaffolding domain mimetic, cavtratin (1 μM) caused a reduction in pMLC (70 ± 5% n = 7, p = 0.001), as did treatment with the scaffolding domain mutant cavnoxin (1 μM) (82 ± 7% n = 7, p = 0.04). …”
-
40060
Data_Sheet_1_Perilymphatic fistula: a historical overview of publication trends.docx
Published 2024“…We hypothesized that publications on PLF have decreased in recent years relative to other inner ear disorders with overlapping symptoms.…”